Insider Buying: Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Director Acquires 50,000 Shares of Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Director Kirk Malloy acquired 50,000 shares of the business’s stock in a transaction dated Thursday, August 8th. The stock was bought at an average cost of $0.91 per share, with a total value of $45,500.00. Following the acquisition, the director now owns 64,300 shares in the company, valued at approximately $58,513. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Rapid Micro Biosystems Trading Up 3.5 %

Shares of Rapid Micro Biosystems stock traded up $0.03 during trading on Friday, hitting $0.88. 51,122 shares of the stock were exchanged, compared to its average volume of 105,015. Rapid Micro Biosystems, Inc. has a 1-year low of $0.58 and a 1-year high of $1.19. The stock has a market capitalization of $37.72 million, a price-to-earnings ratio of -0.70 and a beta of 1.06. The company has a fifty day moving average price of $0.72 and a 200-day moving average price of $0.86.

Rapid Micro Biosystems (NASDAQ:RPID) last released its quarterly earnings data on Friday, August 2nd. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.01). The company had revenue of $6.62 million during the quarter, compared to analyst estimates of $6.02 million. Rapid Micro Biosystems had a negative net margin of 224.73% and a negative return on equity of 42.25%. During the same quarter in the prior year, the firm earned ($0.33) earnings per share. Equities research analysts forecast that Rapid Micro Biosystems, Inc. will post -1.09 EPS for the current fiscal year.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.